Sign in

Balance Sheet - Immunovant, Inc. (IMVT)

$(Billion, Million)
Mar-26 Mar-25 Mar-24 Mar-23 Mar-22 Mar-21 Mar-20 Mar-19 Mar-18
Total cash and short-term investments + 0.90 0.71 0.64 0.38 0.49 0.40 0.10 0.00 0.00
Accounts receivable, net 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00
Inventories -0.02 0.00 0.00 0.00
Other current assets 0.04 0.05 0.02 0.03 0.01 0.01 0.01 0.00 0.00
Total current assets 0.95 0.77 0.67 0.40 0.51 0.41 0.11 0.00 0.00
Total non-current assets + 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total assets 0.96 0.78 0.67 0.41 0.52 0.41 0.11 0.00 0.00
Total current liabilities + 0.10 0.07 0.05 0.04 0.04 0.02 0.02 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Total liabilities 0.10 0.07 0.05 0.04 0.05 0.02 0.02 0.00 0.00
Total stockholders' equity + 0.85 0.71 0.62 0.36 0.47 0.39 0.09 0.00 0.00
Common shares outstanding 182 152 138 123 110 88 43 14 10
Show Quarterly Balance Sheet

Balance Sheet - Immunovant, Inc. (IMVT)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18
Total cash and short-term investments + 0.90 0.99 0.52 0.60 0.71 0.37 0.47 0.56 0.64 0.69 0.27 0.33 0.38 0.43 0.41 0.43 0.49 0.53 0.56 0.38 0.40 0.42 0.44 0.28 0.10 0.12 0.12 0.12 0.00 0.00 0.00 0.00
Accounts receivable, net 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other current assets 0.04 0.05 0.05 0.05 0.05 0.04 0.03 0.03 0.02 0.02 0.02 0.02 0.03 0.02 0.02 0.02 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00
Total current assets 0.95 1.04 0.57 0.65 0.77 0.41 0.51 0.59 0.67 0.71 0.29 0.35 0.40 0.45 0.43 0.46 0.51 0.54 0.56 0.38 0.41 0.43 0.45 0.29 0.11 0.13 0.00 0.00 0.00
Total non-current assets + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 0.12 0.00
Total assets 0.96 1.05 0.58 0.66 0.78 0.42 0.52 0.59 0.67 0.71 0.29 0.35 0.41 0.46 0.43 0.46 0.52 0.54 0.57 0.39 0.41 0.43 0.45 0.29 0.11 0.13 0.12 0.12 0.00
Total current liabilities + 0.10 0.07 0.06 0.05 0.07 0.07 0.07 0.05 0.05 0.03 0.04 0.05 0.04 0.04 0.03 0.02 0.04 0.04 0.03 0.02 0.02 0.02 0.01 0.02 0.02 0.01 0.00 0.00 0.00
Total non-current liabilities + 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total liabilities 0.10 0.07 0.06 0.05 0.07 0.07 0.07 0.05 0.05 0.03 0.04 0.05 0.04 0.04 0.03 0.02 0.05 0.04 0.03 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.00 0.00 0.00 0.00
Total stockholders' equity + 0.85 0.99 0.52 0.61 0.71 0.35 0.45 0.54 0.62 0.68 0.25 0.30 0.36 0.41 0.40 0.44 0.47 0.51 0.54 0.37 0.39 0.41 0.44 0.27 0.09 0.11 0.11 0.11 0.00 0.00
Common shares outstanding 204 182 174 171 152 147 146 146 145 145 131 131 130 129 117 117 116 115 109 98 98 98 98 84 71 41 41 3 3 37 18 10
1 day ago